Contribution of glutamatergic dysfunction to schizophrenia

Drug News and Perspectives

Volumn 9, Issue 8, 1996, Pages 453-459

  Lidsky, T I ^a   Banerjee, S P ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DIZOCILPINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; GLYCINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PSYCHEDELIC AGENT;

ANIMAL MODEL; DOPAMINERGIC SYSTEM; HUMAN; HYPOTHESIS; NEUROTRANSMISSION; NONHUMAN; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 0029958337     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)